Ho Young Lim

612 total citations
19 papers, 481 citations indexed

About

Ho Young Lim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ho Young Lim has authored 19 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Ho Young Lim's work include Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Ho Young Lim is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Ho Young Lim collaborates with scholars based in South Korea, United States and Italy. Ho Young Lim's co-authors include Ana Ruiz-Garcı́a, Silvana Lanzalone, Éric Raymond, Xun Lin, Charles S. Harmon, Jean-Yves Douillard, Magaly Zappa, Éveline Boucher, María José Lechuga and Ann‐Lii Cheng and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and The Oncologist.

In The Last Decade

Ho Young Lim

17 papers receiving 468 citations

Peers

Ho Young Lim
Diyu Huang China
Viola Baradari Germany
Ken Kojo Japan
Adrian Goldiș Romania
Shuguang Ju China
Yu‐Chuan Yan China
Andrea Pretta Italy
Menno T. de Bruijn Netherlands
Diyu Huang China
Ho Young Lim
Citations per year, relative to Ho Young Lim Ho Young Lim (= 1×) peers Diyu Huang

Countries citing papers authored by Ho Young Lim

Since Specialization
Citations

This map shows the geographic impact of Ho Young Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Young Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Young Lim more than expected).

Fields of papers citing papers by Ho Young Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Young Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Young Lim. The network helps show where Ho Young Lim may publish in the future.

Co-authorship network of co-authors of Ho Young Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Young Lim. A scholar is included among the top collaborators of Ho Young Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Young Lim. Ho Young Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Jo, Hyunji, Hong-Sik Kim, Jung Yong Hong, et al.. (2022). A Comparison of Folinic Acid, Fluorouracil and Irinotecan (FOLFIRI) plus Bevacizumab and FOLFIRI plus Aflibercept as Second-line Treatment for Metastatic Colorectal Cancer. Clinical Oncology. 34(8). e323–e328. 2 indexed citations
4.
5.
Lim, Ho Young, et al.. (2019). Effect of needle type on intravascular injection in transforaminal epidural injection: a meta-analysis. The Korean journal of pain. 32(1). 39–39. 2 indexed citations
6.
Son, Eun Jin, et al.. (2011). Classification of trace patterns of 226- and 1000-Hz tympanometry in healthy neonates. Auris Nasus Larynx. 39(5). 455–460. 14 indexed citations
7.
Lee, Jae‐Lyun, Jin‐Hee Ahn, Se Hoon Park, et al.. (2011). Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum. Investigational New Drugs. 30(5). 1984–1990. 52 indexed citations
8.
Nhiệm, Nguyễn Xuân, Ho Young Lim, Phan Văn Kiệm, et al.. (2011). Oleanane-type triterpene saponins from the bark of Aralia elata and their NF-κB inhibition and PPAR activation signal pathway. Bioorganic & Medicinal Chemistry Letters. 21(20). 6143–6147. 41 indexed citations
9.
Kim, S.T., Ji Young Park, Jun Ho Lee, et al.. (2010). The Efficacy of the Frontline Platinum-based Combination Chemotherapy in Malignant Peritoneal Mesothelioma. Japanese Journal of Clinical Oncology. 40(11). 1031–1036. 4 indexed citations
10.
Kim, Chul, Jae‐Lyun Lee, Min‐Hee Ryu, et al.. (2009). A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer. Investigational New Drugs. 29(2). 366–373. 68 indexed citations
11.
Faivre, Sandrine, Éric Raymond, Éveline Boucher, et al.. (2009). Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study. The Lancet Oncology. 10(8). 794–800. 219 indexed citations
12.
Jeung, Hei‐Cheul, Sun Young Rha, Hoon Kyo Kim, et al.. (2007). Multi-Institutional Phase II Study of S-1 Monotherapy in Advanced Gastric Cancer with Pharmacokinetic and Pharmacogenomic Evaluations. The Oncologist. 12(5). 543–554. 30 indexed citations
13.
14.
Kang, Won Ki, Jieun Kwon, Hong-Sik Kim, et al.. (2006). A phase II study of irinotecan, oxaliplatin, 5-fluorouracil, leucovorin (FOLFOXIRI) as a first-line chemotherapy in metastatic gastric cancer. Journal of Clinical Oncology. 24(18_suppl). 4076–4076. 1 indexed citations
15.
Suh, Kwang Wook, Bong‐Wan Kim, Mison Chun, & Ho Young Lim. (2002). Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?. PubMed. 49(44). 399–403. 2 indexed citations
16.
Lee, Kwan Woo, et al.. (2001). Two Cases with Squamous Cell Carcinoma of the Thyroid Gland. Journal of Korean Endocrine Society. 13(3). 446–452. 3 indexed citations
17.
Sheen, Seung Soo, et al.. (2001). Clinical Significance of Vascular Endothelial Growth Factor in Patients with Lung Cancer and Tuberculous Pleurisy. Tuberculosis and Respiratory Diseases. 50(2). 171–171. 1 indexed citations
18.
Koh, Eun Hee, Hyun Cheol Chung, Kyi Beom Lee, et al.. (1992). The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy. Yonsei Medical Journal. 33(2). 137–137. 23 indexed citations
19.
Chung, Hyun Cheol, Ho Young Lim, Eun Hee Koh, et al.. (1991). Coexisting mycosis fungoides and Hodgkin's disease as a composite lymphoma: a case report. Yonsei Medical Journal. 32(4). 362–362. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diyu Huang Breakdown of academic impact, for papers by Viola Baradari Breakdown of academic impact, for papers by Ken Kojo Breakdown of academic impact, for papers by Adrian Goldiș Breakdown of academic impact, for papers by Shuguang Ju Breakdown of academic impact, for papers by Yu‐Chuan Yan Breakdown of academic impact, for papers by Andrea Pretta Breakdown of academic impact, for papers by Menno T. de Bruijn
Rankless by CCL
2026